EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases

N Koho, M M Rajamäki, S J Viitanen iD

Veterinary Clinical Pathology · 2024

DOI: 10.1111/vcp.13353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Clinical Pathology, 2024. Verfasst von N Koho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Dog Diseases, Biomarkers, Procalcitonin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terveyden Tutkimuksen Toimikunta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Procalcitonin (PCT) is a useful biomarker in humans in the identification of bacterial respiratory infections.

Objectives

The aim of this study was to investigate the utility of serum PCT measurements as a diagnostic biomarker in canine bacterial lower respiratory tract diseases.

Methods

PCT concentrations were measured in serum samples with an ELISA method previously validated for dogs. All dogs underwent thorough clinical examinations, and the diagnosis of respiratory disease was based on clinical and laboratory findings, diagnostic imaging, as well as cytology and bacterial culture of respiratory samples. PCT concentrations between different cohorts of dogs were compared with an ANOVA‐model.

Results

Sixty‐two privately owned dogs with respiratory diseases, 25 with bacterial pneumonia (BP), 17 with bacterial bronchitis caused by Bordetella bronchiseptica (BB), and 20 with chronic bronchitis (CB) as well as 44 healthy controls were included in the study. Serum PCT concentrations in dogs with bacterial respiratory diseases (BP mean 51.8 ng/L ± standard deviation [SD] 40.6 ng/L and BB mean 61.4 ng/L ± SD 35.3 ng/L) were not significantly different when compared with dogs with a non‐bacterial respiratory disease (CB mean 89.7 ± SD 73.5 ng/L) or healthy dogs (mean 51.0 ng/L ± SD 37.5 ng/L, p > .05 in all comparisons).

Conclusions

These results indicate that despite being a valuable diagnostic, prognostic, and follow‐up marker in humans with pneumonia, serum PCT concentrations are not elevated in dogs with bacterial respiratory diseases and, therefore, cannot be used as a diagnostic biomarker in dogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesBiomarkersProcalcitoninAnimalsDogsMaleFemaleRespiratory Tract InfectionsPneumonia, BacterialBordetella bronchiseptica

Stichwörter der Autor:innen

bacterial bronchitischronic bronchitisdogpneumonia

Substanzen

BiomarkersProcalcitonin

Autor:innen und Institutionen

  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.

ORCID-Profile: S J Viitanen

Förderung

  • Terveyden Tutkimuksen Toimikunta

Zitieren

APA

Koho, N., Rajamäki, M. M., & Viitanen, S. J. (2024). Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13353

Vancouver

Koho N, Rajamäki MM, Viitanen SJ. Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases. Veterinary Clinical Pathology. 2024. doi:10.1111/vcp.13353

BibTeX
@article{Koho2024,
  author = {Koho, N and Rajamäki, M M and Viitanen, S J},
  title = {Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases},
  journal = {Veterinary Clinical Pathology},
  year = {2024},
  doi = {10.1111/vcp.13353}
}
Kostenlos starten →